3billion is pleased to announce our participation in the upcoming conference โGenomic Technologies for Diagnostics and Treatment of Orphan Diseases in Kazakhstanโ, which will take place on September 25โ26, 2025, at Rahat Palace, Almaty, Kazakhstan.
Programs
As part of the scientific program, our colleagues will deliver the following sessions on September 25:
๐ Progress in Rare Disease Diagnostics: Genetic Testing from 3billion
๐จโ๐ผ Minsoo Kim, Sales Manager, Global Business, 3billion, Inc.
๐ Clinical Exome/Genome Sequencing in 60,000 Patients with Rare Genetic Disorders
๐ฉโโ๏ธ Dr. Gohun Seo, Chief Medical Officer, 3billion, Inc.
In addition, distinguished local experts from Kazakhstan will present their research on September 26:
๐ Genetic Diagnosis of Rare Neurological Syndromes in Children
๐ฉโโ๏ธ Dr. Bakhytkul Myrzaliyeva, Senior Lecturer, Department of Neurology, Kazakhstan-Russian Medical University (Almaty, Kazakhstan)
๐ Exome Sequencing in Clinical Practice: From Deep Phenotyping to Diagnosis
๐ฉโโ๏ธ Dr. Nigara Khalmakhammetovna Yerkhojayeva, Neurologist & PhD Doctoral Student, Khoja Akhmet Yassawi International Kazakh-Turkish University (Turkestan, Kazakhstan)
3billion is honored to contribute to this important event, joining with leading Kazakhstani clinicians and researchers to advance rare disease diagnostics and genomic medicine in the region.
We look forward to connecting with the medical community in Almaty and sharing how genomic testing is transforming patient care.
๋ต๊ธ ๋จ๊ธฐ๊ธฐ
๋๊ธ์ ๋ฌ๊ธฐ ์ํด์๋ ๋ก๊ทธ์ธํด์ผํฉ๋๋ค.